Douglas Scharre, MD

Physician, Professor

Neurology

Make an appointment

614-293-4969
Accepting new patients

Conditions and expertise

  • Alzheimer Disease
  • Memory Disorders
  • Mild Cognitive Impairment
  • Cognitive Neurology
  • Delirium, Dementia, Amnestic, Cognitive Disorders
  • Frontotemporal Dementia

View all conditions

Locations

  • Outpatient Care New Albany
  • Neurology

View all locations

Academics and research

Department: Neurology

View my research

About

Gender
Male

Biography

I am the medical director of the Center for Cognitive and Memory Disorders at The Ohio State University, a clinical researcher, and am a master clinician (Mazzaferri-Ellison Society of Master Clinicians) regarding diagnosis and management of cognitive issues.

As a cognitive and behavioral neurologist, I specialize in diagnosis and treatment of neurodegenerative disorders including Alzheimer's disease dementia with Lewy bodies, and frontotemporal lobar degenerations.

Every patient and family deserves to be informed and educated on their medical issues and potential research opportunities. Patients at The Ohio State University Wexner Medical Center benefit from new discoveries and scientific advances as we strive to provide you with the best possible care.

I have been selected by my peers as one of the “Best Doctors in America” for the last 21 years in a row. Everything I do in research, education and clinical care is focused on improving the lives of patients and caregivers with cognitive disorders and dementia conditions.

Highlights

  • Director, Division of Cognitive Neurology
  • Medical Director, Neurobehavior and Memory Disorders Clinics
  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2015, 2017, 2019
  • Named to “Best Doctors in America" and “Castle Connolly Top Doctors”

Conditions and expertise

  • Alzheimer Disease
  • Central Nervous System Diseases
  • Cognitive Neurology
  • Delirium, Dementia, Amnestic, Cognitive Disorders
  • Frontotemporal Dementia
  • Lewy Body Disease
  • Memory Disorders
  • Mild Cognitive Impairment
  • Normal Pressure Hydrocephalus

Locations

Neurology

in Martha Morehouse Outpatient Care
2050 Kenny Road
Pavilion 3rd Floor Suite 3100
Columbus, OH 43221
614-293-4969

Please note: Not all physicians schedule patients at each listed location.

Credentials

Education

Fellowship - Behavioral Neurology & Neuropsychiatry
Mattel Children's Hospital at UCLA Medical Center, Los Angeles, CA
7/1/1991 - 6/30/1993
Residency - Neurology
Letterman Army Medical Center, San Francisco, CA, USA
7/1/1984 - 6/1/1987
Internship - Internal Medicine
William Beaumont Army Medical Center, Fort Bliss, TX, United States
7/1/1983 - 6/30/1984
Doctor of Medicine (MD)
Georgetown University School of Medicine, Washington, DC
8/1/1979 - 5/1/1983

Certifications

  • American Heart Association National Center
    8/1/2001
  • American Board of Psychiatry & Neurology-Neurology
    3/30/1990

Academics and research

I have conducted more than 250 cognitive and dementia related multi-center and investigator-initiated clinical trials funded by the National Institutes of Health (NIH), by foundations, and by the industry in my career of more than 30 years. These studies have utilized neuroimaging, serum and cerebrospinal fluid biomarkers, cognitive biomarkers, genetic biomarkers, and cognitive, functional and behavioral scales on mild cognitive impairment, dementia and control subjects. The data from these research subjects who participated in studies at our Ohio State University Memory Disorders Research Center have contributed to over 5,000 research publications.

I am a contributing member of several national research and NIH-supported consortiums including the Alzheimer's Clinical Trials Consortium (ACTC) and the Alzheimer’s Disease Cooperative Study (ADCS) group. I have participated in all the Alzheimer’s Disease Neuroimaging Initiative (ADNI) projects, and I am a member of the steering committee for ADNI. My research center is also designated as one of the funded Lewy Body Dementia Association Research Centers of Excellence, where he currently serves on the clinical management best practices committee.

I have designed and developed both paper and digital versions of the Self-Administered Gerocognitive Examination (SAGE), a cognitive assessment instrument designed for identifying individuals in a practical way with mild cognitive impairment or early dementia from any cause and to be sensitive to changes over time. Comprehensive validation was published in 2010 and it was revalidated in a separate European cohort in 2025. Normative data from a community sample of more than 1,000 individuals was published in 2014. Validation of a tablet-based electronic SAGE (BrainTest) was published in 2017. Longitudinal cohort testing for detection of dementia conversion was published in 2021. Declining SAGE scores of 2-3 points indicated a high risk for eventual dementia and this was noted at least six months earlier than changes in the Mini Mental State Examination. Its use in primary care visits was published in 2024. SAGE is available free online for clinical use (www.sage.osu.edu), and BrainTest is available through EPIC for health care systems and online for individual use (https://braintest.com). SAGE has been downloaded over 4 million times.

One current project is my NIH R01 grant exploring the integration of eSAGE (BrainTest) with electronic medical record data using machine learning for the early detection and monitoring of cognitive impairment in individuals including those underserved. Ongoing studies also include therapeutic trials for those with mild cognitive impairment, Alzheimer's disease dementia, frontotemporal dementia, Lewy body disease, behavioral disturbances with dementia, and those at risk for dementia conditions, utilizing medications, gene therapies and devices.

I have studies involved with biofluid banking, genetic testing, and testing for new fluid, imaging and cognitive biomarkers. My future research goals include investigating best practices to collaborate with patients, families and primary care providers to speed up the time from first cognitive complaint to identification of a cognitive issue, diagnosis and then appropriate treatments.

Research interests

  • Alzheimer Disease
  • Central Nervous System Diseases
  • Cognitive Neurology
  • Delirium
  • Dementia
  • Amnestic
  • Cognitive Disorders
  • Dementia
  • Frontotemporal Dementia
  • Lewy Body Disease
  • Memory Disorders
  • Mild Cognitive Impairment
  • Normal Pressure Hydrocephalus

Research Methods

  • Case Studies
  • Quantitative Research
  • Quantitative: Observational Studies
  • Quantitative: Randomized control trials (RTCs)
  • Quantitative: Surveys and Questionnaires
  • Secondary Data Analysis/Real World Data
  • Systematic Review and Meta Analysis

Academic information

Department:
Neurology
Division:
Neurology

More about my research

Ratings and reviews

The overall patient satisfaction rating is an average of all patient responses to the six doctor communication related questions shown below from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems survey. For additional information about the patient satisfaction survey, please visit our Patient Satisfaction Survey page.

The comments are submitted by patients and reflect their view and opinions. The comments are not endorsed by and do not necessarily reflect the views of Ohio State Wexner Medical Center.

118 Patient Satisfaction Reviews

4.9 out of 5 overall
  • Explains Things Carefully
    4.8 / 5
  • Listens Carefully
    4.9 / 5
  • Gives Understandable Instructions
    4.8 / 5
  • Knows My Medical History
    4.9 / 5
  • Shows Respect
    4.9 / 5
  • Time Spent Together
    4.9 / 5

Patient Comments

  • Reviewed on Nov 04, 2025

    Good

  • Reviewed on Oct 31, 2025

    Very caring

  • Reviewed on Oct 21, 2025

    The doctor was so wonderful and spent a lot of time with us

  • Reviewed on Oct 15, 2025

    Dr Scharre has been very thoughtful and helpful

  • Reviewed on Oct 11, 2025

    Good experience

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 11/3/2025 Dr. Scharre has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • Biogen
  • Brain Test, Inc.
  • Cognition Therapeutics
  • Eisai, Inc.
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Office of the Federal Public Defender

Subscribe. Get just the right amount of health and wellness in your inbox.